{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+Ulcerative+Colitis", "query": { "condition": "Moderate Ulcerative Colitis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 235, "total_pages": 24, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+Ulcerative+Colitis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-05T05:42:07.985Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05156125", "title": "VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "VTX002", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oppilan Pharma Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 213, "start_date": "2021-11-30", "completion_date": "2025-03-13", "has_results": true, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 19, "location_summary": "Garden Grove, California • Lancaster, California • San Diego, California + 16 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Kissimmee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05156125" }, { "nct_id": "NCT03259334", "title": "Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Ontamalimab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 380, "start_date": "2018-02-09", "completion_date": "2020-10-23", "has_results": true, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 38, "location_summary": "Little Rock, Arkansas • Lancaster, California • Rialto, California + 31 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lancaster", "state": "California" }, { "city": "Rialto", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03259334" }, { "nct_id": "NCT02647866", "title": "Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis", "Digestive System Diseases", "Colitis, Ulcerative", "Colitis", "Gastrointestinal Diseases", "Inflammatory Bowel Diseases", "Intestinal Diseases", "Colonic Diseases", "Autoimmune Disease", "Abdominal Pain" ], "interventions": [ { "name": "KHK4083", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kyowa Kirin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2016-06", "completion_date": "2018-10", "has_results": true, "last_update_posted_date": "2024-04-26", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 1, "location_summary": "Greenville, South Carolina", "locations": [ { "city": "Greenville", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02647866" }, { "nct_id": "NCT05785715", "title": "Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "NX-13 250mg", "type": "DRUG" }, { "name": "NX-13 750mg", "type": "DRUG" }, { "name": "NX-13 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 81, "start_date": "2023-04-24", "completion_date": "2025-05-30", "has_results": true, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 11, "location_summary": "Miami, Florida • Orlando, Florida • Tampa, Florida + 8 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chesterfield", "state": "Michigan" }, { "city": "Troy", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05785715" }, { "nct_id": "NCT06764615", "title": "A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease", "Ulcerative Colitis" ], "interventions": [ { "name": "Zasocitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 192, "start_date": "2025-05-28", "completion_date": "2029-12-30", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 2, "location_summary": "Glen Burnie, Maryland • Tyler, Texas", "locations": [ { "city": "Glen Burnie", "state": "Maryland" }, { "city": "Tyler", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06764615" }, { "nct_id": "NCT01240915", "title": "A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "MultiStem low dose", "type": "DRUG" }, { "name": "MultiStem high dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2011-02", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2016-02-23", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 37, "location_summary": "San Francisco, California • Lafayette, Colorado • Lakewood, Colorado + 24 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Lafayette", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Littleton", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01240915" }, { "nct_id": "NCT06260267", "title": "A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Microbiota suspension", "type": "DRUG" }, { "name": "Microbiota capsule", "type": "DRUG" }, { "name": "Placebo suspension", "type": "DRUG" }, { "name": "Placebo capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ferring Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2024-03-12", "completion_date": "2026-01-15", "has_results": false, "last_update_posted_date": "2024-10-18", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 10, "location_summary": "North Little Rock, Arkansas • Hamden, Connecticut • Inverness, Florida + 7 more", "locations": [ { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Hamden", "state": "Connecticut" }, { "city": "Inverness", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orange City", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06260267" }, { "nct_id": "NCT07158242", "title": "A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderately to Severely Active Ulcerative Colitis" ], "interventions": [ { "name": "Afimkibart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 100, "start_date": "2026-04-15", "completion_date": "2031-03-31", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 5, "location_summary": "Aurora, Colorado • Tampa, Florida • Atlanta, Georgia + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Lake Success", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07158242" }, { "nct_id": "NCT01294410", "title": "Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Anti-IP-10 Antibody", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 305, "start_date": "2011-03", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-06-25", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 23, "location_summary": "La Jolla, California • Santa Monica, California • Wheat Ridge, Colorado + 20 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Winter Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01294410" }, { "nct_id": "NCT06867094", "title": "A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colitis Ulcerative" ], "interventions": [ { "name": "SAR441566", "type": "DRUG" }, { "name": "SAR441566 matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 204, "start_date": "2025-03-28", "completion_date": "2026-10-14", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-05T05:42:07.985Z", "location_count": 19, "location_summary": "Sun City, Arizona • Bristol, Connecticut • Clermont, Florida + 16 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Bristol", "state": "Connecticut" }, { "city": "Clermont", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06867094" } ] }